{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-184587","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2023-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.054300+00:00","generated_at":"2026-06-13T10:32:55.930018+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Soleno Therapeutics files 8-K with corporate presentation; no specific results disclosed","bullets":["Presentation furnished under Regulation FD; no financial metrics or guidance provided in filing.","Company is a clinical-stage biotech focused on Prader-Willi syndrome; pipeline update likely in exhibit.","No material event such as earnings, M&A, or leadership change announced in this 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-184587","json":"https://secwatch.observer/filing/0001193125-23-184587.json","markdown":"https://secwatch.observer/filing/0001193125-23-184587.md","text":"https://secwatch.observer/filing/0001193125-23-184587.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523184587/0001193125-23-184587-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523184587/d528883d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:32:55.930018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}